All Type of News
National Assembly debate on NHI drug price approval.
Rep. Kang Ki-jeong of Uri Party, a member of the National Assembly, Health and Welfare Committee, said on June 10 in the interpellation meeting that the NHI drug pricing policy should be ameliorated currently from the...
Dong-A's impotence drug under research to name Zydena.
Dong-A's DA-8150, a new impotence drug under research, seems to name Zydena after the final approval by Chairman Kang Shin-ho.
In the international male science meeting on June 14 Dong-A may report the phase III st...
8.2 billion won of pharmacy service fees cut off in 2004.
The total 8.2 billion won of pharmacy service (dispensing) fees cut off in 2004 by applying the government's discriminated payment system, which was 9 times more than 2002.
The Health Insurance Review Agency (HIRA)...
Safety control on blood of umbilical cord to be legislated.
Rep. Ahn Myeong-ok of National Assembly Health and Welfare Committee and the Grand National Party raised a bill titled "Bill for the safety control and studies on the blood of umbilical cord" to the National Assembly ...
Non-prescription drugs to convert more to quasi-drugs
The MOHW plans to transfer more non-prescription drugs having far broader range of safety with minor adverse reactions to the quasi-drugs for free sale at retail stores or general supermarkets during the second half o...
Daewoong selected their regional associated wholesalers.
Daewoong has completed to select their associated wholesalers and notified them individually, including 6 in Youngnam, 3 in Homan, 3 in Choongcheong province and 2 in Gangwon province. The nomination of their associat...
KHIDI and Novartis jointly to hold seminar for new drug R&D.
The Korea Health Industry Development Institute and Novartis, a big swiss drug company, announced to hold a seminar titled "A multinational drug corporation's strategy of new drug development" at Dynasty room of Shill...
No health food production at antibiotic manufacturing facilities.
Most of health food supplements are granted to manufacture at the pharmaceutical facilities except the areas of producing antibiotics, biological, ointment, radiology, human growth hormone, narcotic and injectable dru...
Small/medium drug companies experiencing duplicate difficulties.
Small and medium sized pharmaceutical companies have faced with duplicated difficulties with the competition against the upper leading rivals and the discriminated assessment system by the GMP.
The small and mediu...
Bill of granting corporate pharmacy likely to pass.
The revised bill of the pharmaceutical affairs act granting the establishment of corporate pharmacy seems to pass through the National Assembly during the extraordinary session in June.
After the interpellation on ...